120 related articles for article (PubMed ID: 15311888)
1. [New 2004 guidelines of the Breast Organ Committee of AGO].
Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
[No Abstract] [Full Text] [Related]
2. American symposium looks at new antineoplastic drug.
Korcok M
Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
[No Abstract] [Full Text] [Related]
3. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
Ventura GJ
J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
[No Abstract] [Full Text] [Related]
4. Chemotherapy of breast cancer. Investigational treatment.
Jones SE
Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
[No Abstract] [Full Text] [Related]
5. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
6. [Use of pharmorubicin in cancer of the breast].
Ass NIa; Borisov VI
Sov Med; 1986; (10):36-9. PubMed ID: 3544240
[No Abstract] [Full Text] [Related]
7. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
Ward HW
Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
[No Abstract] [Full Text] [Related]
8. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
Palmer RL; Samal BA; Vaughn CB; Tranum BL
Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
[No Abstract] [Full Text] [Related]
10. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
Minisini AM; Andreetta C; Fasola G; Puglisi F
Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
Campora E; Nobile MT; Sertoli MR; Rosso R
Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
[No Abstract] [Full Text] [Related]
12. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
Buchholz TA; Tu X; Ang KK; Esteva FJ; Kuerer HM; Pusztai L; Cristofanilli M; Singletary SE; Hortobagyi GN; Sahin AA
Cancer; 2005 Aug; 104(4):676-81. PubMed ID: 15981280
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin for metastatic breast cancer: time for a change?
Muggia F
Cancer Invest; 2003; 21(6):967-8. PubMed ID: 14735701
[No Abstract] [Full Text] [Related]
14. Chemotherapy-induced subacute lupus erythematosus.
Guhl G; Diaz-Ley B; García-García C; Fraga J; Garcia-Diez A
Lupus; 2009 Aug; 18(9):859-60. PubMed ID: 19578115
[No Abstract] [Full Text] [Related]
15. [Liposomal doxorubicin in patients with breast cancer and concomitant cardiovascular diseases - interdisciplinary expert opinion].
Szmit S; Filipiak KJ; Litwiniuk M; Opolski G; Wysocki P; Zaborska B; Krzakowski M
Kardiol Pol; 2016; 74(9):1031-6. PubMed ID: 27654476
[TBL] [Abstract][Full Text] [Related]
16. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
[No Abstract] [Full Text] [Related]
17. Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.
Rudzinski T; Ciesielczyk M; Religa W; Bednarkiewicz Z; Krzeminska-Pakula M
Europace; 2007 May; 9(5):278-80. PubMed ID: 17383986
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological absence of cardiotoxicity after liposomal doxorubicin.
Jones RL; Berry GJ; Rubens RD; Miles DW
Lancet Oncol; 2004 Sep; 5(9):575-7. PubMed ID: 15337488
[No Abstract] [Full Text] [Related]
19. Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.
Carlson RW; Billingham ME; Kohler M; Johnson FD; Doroshow JH; Torti FM
Cancer Treat Rep; 1987 Apr; 71(4):427-8. PubMed ID: 3548961
[No Abstract] [Full Text] [Related]
20. [Improving prognosis with docetaxel and monoclonal antibodies].
Krankenpfl J; 2005; 43(7-10):233. PubMed ID: 16515303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
